Betsabeh Madani Hermann becomes business and strategy advisor of Perceiv AI

April 14, 2021


Perceiv AI is thrilled to welcome Betsabeh Madani Hermann as a business and strategy advisor to the company.

Betsabeh is a strategy and innovation executive seasoned in general operations, commercialization, growth planning and execution. She has built and nurtured impactful products and teams globally across health and tech companies with 3-26K employees and $5M-$26B market cap (notably at Cerner, Equicare Health, Borealis Ventures, The Commons Project, BCG and Mitacs).

She serves as a mentor to Dartmouth's Innovation Accelerator in Oncology, Weill Cornell’s Medicine's BioVenture Lab, Vancouver General Hospital's Innovators and is on Ontario Biosciences CAAP and Quebec’s IRICOR LeadAction committees.

She holds an MBA from Dartmouth’s Tuck School of Business, a Master of Engineering in Biomechanical Engineering from UBC, and Honors Bachelors in both Physics and Biochemistry from UVic.

“I am humbled and excited to work more closely with Betsabeh, her wealth of experience will greatly help us position ourselves as a leading provider of predictive insight.” said Christian Dansereau, Ph.D., CEO and co-founder of Perceiv AI.

About Perceiv AI

Founded in 2018, Perceiv AI is a precision medicine technology company dedicated to improving treatment efficacy through refined patients selection. Thanks to multiple partnerships with pharmaceutical companies, hospitals and research centers, Perceiv AI is developing digital biomarkers to help clinical trials succeed by pairing multimodal biomedical data and proprietary artificial intelligence technology to target the most suitable patients. Our turn-key solutions can be used for prognostic enrichment and for precise targeting of responders to a particular therapeutic intervention. Headquartered in Montreal, Canada, Perceiv AI is helping build the future of precision medicine. For more information, visit us at www.perceiv.ai